Welcome to our dedicated page for Quanex Building Products SEC filings (Ticker: NX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Quanex Building Products's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Quanex Building Products's regulatory disclosures and financial reporting.
Quanex Building Products (NX) reported a director’s equity award on Form 4. The filing shows the grant of 8,045 restricted stock units on 11/03/2025.
The RSUs vest immediately and represent a right to receive cash equal to the value of one share of Quanex common stock. Payment occurs upon death, disability, the director’s cessation of service, or a change of control.
After this transaction, the director beneficially owned 12,308 derivative securities, held directly.
Quanex Building Products (NX) reported a director equity transaction. On 11/04/2025, the director acquired 8,045 restricted stock units (RSUs) at $0 per unit. Each RSU represents a contingent right to receive cash equal to the value of one share of Quanex common stock. The RSUs vest immediately and become payable upon the grantee’s death, disability, cessation of service as a director, or a change in control of the company. Following the transaction, the director reported 36,509 derivative securities held directly.
Quanex Building Products (NX) reported a director equity grant on a Form 4. On 11/03/2025, the director acquired 8,045 restricted stock units at $0. These RSUs vest immediately and each represents a right to receive cash equal to the value of one share, payable upon death, disability, end of board service, or a change in control. Following the transaction, derivative securities beneficially owned were 24,955, held directly.
Quanex Building Products (NX) reported an insider equity grant. A director acquired 8,045 restricted stock units on 11/03/2025 (Transaction Code A).
The RSUs vest immediately and will pay out on the earlier of the third anniversary of grant or upon the director’s death, disability, cessation of service, or a change in control. Following the grant, the director directly beneficially owns 23,248 derivative securities. The derivative price is listed as $0.
Quanex Building Products (NX) director reported the grant of 8,045 Restricted Stock Units on November 3, 2025 (Transaction Code A). Each RSU represents a contingent right to receive cash equal to the value of one share of Quanex common stock.
The RSUs vest immediately and pay out upon death, disability, cessation of service as a director, or change in control. Following the grant, the reporting person beneficially owned 12,308 derivative securities, held directly, at a stated price of $0 per unit.
Quanex Building Products (NX) reported an insider equity award. A company director acquired 8,045 restricted stock units on 11/03/2025 as disclosed on Form 4 Table II. Each RSU represents a contingent right to receive cash equal to the value of one share of Quanex common stock.
The RSUs vest immediately and will pay out upon the director’s death, disability, cessation of board service, or a change in control. Following the transaction, the director beneficially owned 8,045 derivative securities, held directly.
Quanex Building Products (NX) reported insider activity by a director. On 11/01/2025, 3,530 restricted stock units (RSUs) vested and were settled in cash, paired with a disposition of 3,530 common shares at $14.21, leaving 0 common shares directly owned. On 11/03/2025, the director received a new grant of 8,045 RSUs. Each RSU represents a right to cash equal to one NX share’s value; the new RSUs vest immediately and are payable on the first anniversary or upon specified events.
Quanex Building Products (NX) reported an initial insider ownership filing. A director filed a Form 3 with an event date of 11/01/2025, stating no securities are beneficially owned. The filing was made by one reporting person and includes Exhibit 24 (Power of Attorney), with the form signed by power of attorney on 10/28/2025.
Quanex Building Products (NX) appointed Mary K. Lawler to its Board of Directors, effective November 1, 2025, with a term ending at the next annual meeting in 2026. Lawler currently serves as Senior Vice President and Chief Human Resources Officer at Illinois Tool Works and brings prior leadership experience from GATX and Tribune Media, following an early legal career.
She will join the Board’s Compensation & Management Development and Nominating & Corporate Governance Committees. Compensation will follow the Company’s standard director practices, including an annual Restricted Stock Unit grant on November 3, 2025, the first business day of the fiscal year. The Company plans to enter into its standard indemnification agreement with her. The filing notes no selection arrangements, no Item 404(a) related-party transactions since November 1, 2023, and no family relationships with Company insiders.
Quanex Building Products (NX) filed a Form 3 for an officer identifying as VP, Chief Accounting Officer. The initial statement under Section 16 reports no securities are beneficially owned as of the event date 10/20/2025. The filing indicates it was submitted by one reporting person and includes an Exhibit 24 Power of Attorney authorizing the signature.